Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth

Cancer Research

Volumn 70, Issue 18, 2010, Pages 7273-7282

  Mellick, Albert S ^a   Plummer, Prue N ^a   Nolan, Daniel J ^b   Gao, Dingcheng ^b   Bambino, Kathryn ^b   Hahn, Mary ^b   Catena, Raul ^b   Turner, Vivian ^c   McDonnell, Kevin ^b   Benezra, Robert ^d   Brink, Robert ^c   Swarbrick, Alexander ^c   Mittal, Vivek ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; INHIBITOR OF DIFFERENTIATION 1; INTRINSIC FACTOR; MICRORNA; MICRORNA 30; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; IDB1 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; DNA BINDING; ENDOTHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STROMA; SUICIDE GENE; TUMOR GROWTH; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL GROWTH; CHICKEN; GENE EXPRESSION PROFILING; GENETICS; LEWIS CARCINOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; STEM CELL; STROMA CELL; TRANSGENIC MOUSE; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHICKENS; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS; STROMAL CELLS; UP-REGULATION;

EID: 77956939901     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1142     Document Type: Article

References (43)

1. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-8.
2. De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005;8:211-26.
3. De Palma M, Mazzieri R, Politi LS, et al. Tumor-targeted interferon-α delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 2008;14:299-311.
4. + cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004;6:409-21.
5. + myeloid cells into tumors. Cancer Res 2009;69:7875-83.
6. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-40.
7. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8.
8. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
9. Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A 2006;103:12493-8.
10. + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005;27:870-9.
11. Kopp HG, Ramos CA, Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 2006;13:175-81.
12. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow derived endothelial progenitor cells. Embo J 1999;18:3964-72.
13. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-53.
14. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201.
15. Ruzinova MB, Schoer RA, Gerald W, et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 2003;4:277-89.
16. Nolan DJ, Ciarrocchi A, Mellick AS, et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007;21:1546-58.
17. Gao D, Nolan DJ, Mellick AS, et al. EPCs control the angiogenic switch in mouse lung metastasis. Science 2008;319:195-8.
18. Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 2006;6:835-45.
19. Shaked Y, Ciarrocchi A, Franco M, et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006;313:1785-7.
20. Gao D, Mittal V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol Med 2009;15:333-43.
21. Purhonen S, Palm J, Rossi D, et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008;105:6620-5.
22. Perk J, Gil-Bazo I, Chin Y, et al. Reassessment of Id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-Id1 antibody. Cancer Res 2006;66:10870-7.
23. Lyden D, Young AZ, Zagzag D, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999;401:670-7.
24. Perry SS, Zhao Y, Nie L, et al. Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance. Blood 2007;110:2351-60.
25. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett 1997;407:313-9.
26. 4-integrin ligands on an endothelial cell line. Biochem Cell Biol 2000;78:99-113.
27. Kumar R, Conklin DS, Mittal V. High-throughput selection of effective RNAi probes for gene silencing. Genome Res 2003;13:2333-40.
28. Rose'Meyer RB, Mellick AS, Garnham BG, et al. The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc 2003;11:9-18.
29. Campbell RE, Tour O, Palmer AE, et al. A monomeric red fluorescent protein. Proc Natl Acad Sci U S A 2002;99:7877-82.
30. Salmon P, Kindler V, Ducrey O, et al. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 2000;96:3392-8.
31. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004;4:648-55.
32. Katagiri T, Imada M, Yanai T, et al. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 2002;7:949-60.
33. Magalhaes GS, Muotri AR, Marchetto MC, Menck CF, Ventura AM. An adenovirus vector containing the suicide gene thymidine kinase for a broad application in cancer gene therapy. Mem Inst Oswaldo Cruz 2002;97:547-52.
34. Lalor PA, Mapp PI, Hall PA, Revell PA. Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int 1987;7:183-6.
35. Osti D, Marras E, Ceriani I, et al. Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes. Virol Methods 2006;136:93-101.
36. Dickins RA, Hemann MT, Zilfou JT, et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005;11:1289-95.
37. Peters BA, Diaz LA, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-2.
38. Duda DG, Cohen KS, Kozin SV, et al. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 2006;107:2774-6.
39. Yan W, Young AZ, Soares VC, et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol 1997;12:7317-27.
40. Jankovic V, Ciarrocchi A, Boccuni P, et al. Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc Natl Acad Sci U S A 2007;104:1260-5.
41. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-7.
42. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006;39:469-78.
43. Gao D, Nolan D, McDonnell K, et al. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 2009;1796:33-40.